Veradermics
Veradermics is a US clinical-stage biopharmaceutical company developing prescription therapies for dermatological conditions. Its pipeline focuses on treatments for androgenetic hair loss as well as other skin disorders such as warts.
Frequently asked questions
When did Veradermics last report quarterly earnings?
Veradermics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.58 USD.
How does Veradermics stock react to earnings?
Across its last 3 earnings reports, Veradermics stock moved by ±4.2% on average the following day. The largest reaction was -7.1% on 03/30/2026; 0 of 3 reactions were positive.
How do I add the Veradermics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.